Prophylactic and Therapeutic Cancer Vaccine with Continuous Localized Immunomodulation DOI

Nikitha Kota,

Daniel Davila Gonzalez, Hsuan‐Chen Liu

и другие.

Опубликована: Янв. 1, 2024

Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI

Язык: Английский

Human Papillomavirus and Associated Cancers: A Review DOI Creative Commons

JaNiese Elizabeth Jensen,

Greta L. Becker, J. Brooks Jackson

и другие.

Viruses, Год журнала: 2024, Номер 16(5), С. 680 - 680

Опубликована: Апрель 26, 2024

The human papillomavirus is the most common sexually transmitted infection in world. Most HPV infections clear spontaneously within 2 years of infection; however, persistent can result a wide array diseases, ranging from genital warts to cancer. cases cervical, anal, and oropharyngeal cancers are due infection, with cervical cancer being one leading causes death women worldwide. Screening available for cancer, but not everywhere, particularly lower-resource settings. disproportionally affects individuals living HIV, resulting decreased clearance, increased development mortality. vaccine has shown drastic decrease HPV-related diseases. prevents near 100% efficacy, if given prior first sexual activity. Vaccination uptake remains low worldwide lack access limited knowledge HPV. Increasing awareness vaccination necessary morbidity mortality

Язык: Английский

Процитировано

29

PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial DOI
Scott M. Norberg, Janet Valdez,

Scott Napier

и другие.

The Lancet Respiratory Medicine, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

2

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV) DOI Creative Commons

Fatemeh Movahed,

Satinik Darzi,

Parya Mahdavi

и другие.

Virology Journal, Год журнала: 2024, Номер 21(1)

Опубликована: Май 31, 2024

Abstract Cervical cancer (CC) and other malignant malignancies are acknowledged to be primarily caused by persistent human papillomavirus (HPV) infection. Historically, vaccinations against viruses that produce neutralizing antibodies unique the virus have been an affordable way manage viral diseases. CC risk is decreased, but not eliminated, HPV vaccinations. Since made available globally, almost 90% of infections successfully avoided. On lesions diseases already present, however, no discernible treatment benefit has shown. As a result, therapeutic vaccines elicit immune responses mediated cells necessary for established cancers. mRNA possess remarkable potential in combating malignancy as result their superior industrial production, safety, efficacy. Furthermore, considering expeditiousness vaccine exhibits promise approach targeting HPV. Given HPV-encoded early proteins, including oncoproteins E6 E7, consistently present HPV-related cancers pre-cancerous crucial functions progression persistence diseases, they serve ideal targets vaccines. The action mechanism vaccines, recent advancements clinical trials, applications highlighted this study, which also offers quick summary state Lastly, we highlight few difficulties with vaccination practice provide our thoughts on further quickly changing sector. It expected will soon produced prevention treatment. Graphical

Язык: Английский

Процитировано

12

Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives DOI
Muhammad Umar Farooq, Charles H. Lawrie, Nan‐Nan Deng

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 486, С. 150356 - 150356

Опубликована: Март 14, 2024

Язык: Английский

Процитировано

9

Socioeconomic and Health-Related Characteristics Associated with Initiation and Completion of Human Papillomavirus Vaccination among Males in the United States: An In-Depth Systematic Review and Meta-Analysis DOI

George N. Okoli,

Alexandra Soós,

Katharine Etsell

и другие.

Behavioral Medicine, Год журнала: 2025, Номер unknown, С. 1 - 22

Опубликована: Янв. 24, 2025

Human papillomavirus (HPV) vaccination among males is poorly understood. We systematically reviewed individual socioeconomic/health-related characteristics associated with HPV vaccine initiation and series completion in the United States. searched for literature up to August 1, 2023, pooled appropriate multivariable-adjusted results using an inverse variance random effects model, expressed as odds ratios. Among pediatric (<18 years old), we observed moderately increased of urban residence, being a Black/Hispanic male versus White male, public private health insurance, visiting care provider past year. Influenza year strongly odds. Further, residence having parent lower/no education completion, whereas influenza adult (≥18 US-born, unemployed, unmarried/separated/divorced/widowed; states Northern Western region; had sexually transmitted infection; gay/bisexual. Younger age, living Southern region, visited higher education, unmarried/separated/divorced/widowed, Black primary physician insurance gay/bisexual These findings may inform age-targeted future program planning.

Язык: Английский

Процитировано

1

From science to sensory art: an inclusive pedagogical tool for the UK blind, low‐vision and diverse‐needs community to increase cervical cancer awareness DOI Open Access
Jhagavan Arunthavalingam,

Caroline Walker,

Arman Ghodsinia

и другие.

Immunology and Cell Biology, Год журнала: 2025, Номер unknown

Опубликована: Март 2, 2025

Abstract Effective scientific communication fosters public support and trust in research, establishing a stronger understanding of health disease. Making STEM education more accessible is crucial for blind, low‐vision diverse‐needs (BLVDN) communities, where grasping complex biomedical concepts can be challenging. Such accessibility promotes equal opportunities encourages innovation through diverse perspectives. This paper examines the Sensory Science Cambridge exhibition, held at Festival March 2024, aiming to enhance BLVDN inspired by Monash Australia. The exhibition included several tactile exhibits, including one designed educate on nature human papillomavirus (HPV) infections their link cervical cancer diorama art piece. We were guided question: How sensory materials convey HPV infection its progression cancer? To achieve this, we developed independent navigation, featuring braille keys, explanatory panels verbal descriptions. was created collaboration between scientists artists, effectiveness evaluated participant feedback observational studies during exhibition. significantly improved participants’ cancer, providing new or building existing knowledge. success this project provides model using education. It highlights potential science approaches making underscores importance interdisciplinary creating accessible, scientifically rigorous tools, offering insights future inclusive outreach.

Язык: Английский

Процитировано

1

Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions DOI Creative Commons

Tamer A. Addissouky,

Ibrahim El Tantawy El Sayed,

Majeed M. A. Ali

и другие.

Journal of Cellular Immunology, Год журнала: 2023, Номер 5(4), С. 127 - 140

Опубликована: Ноя. 29, 2023

Background: Cancer remains a leading cause of mortality with modest declines, highlighting the need for more efficacious prevention strategies like early immunological intervention against premalignant disease. Main body abstract: Oncogenic viruses demonstrate prophylactic vaccines can successfully reduce malignancy by blocking precipitating infections. However, most cancers lack viral etiology, requiring novel approaches targeting sporadic precancerous states to enable immunoprevention. Preneoplastic tissues exhibit biological changes making them appealing targets stimulating immune surveillance before additional mutations unconstrained proliferation. High-risk precancers also provide sources dysregulated self-antigens. Yet challenges exist in lesion identification, overcoming tolerance, and avoiding inflammation potentially worsening progression. Multidisciplinary insights into precancer immunology, predictive biomarkers, antigen discovery, combinatorial vaccination are illuminating rational vaccine design. Despite obstacles, immunization dysplastic holds disruptive potential if key steps advance this approach. Elucidating preneoplasia immunobiology progression risk modeling will be critical guide productive while mitigating immunotherapy hazards. Thoughtful translation could eventually shift paradigms priming immunosurveillance peak vulnerability lesions. Short Conclusion: Advancements may profoundly expand horizons. Cautious intercept toward widely disseminated malignancies. This warrants methodical efforts unravel promise thwarting lethal they start.

Язык: Английский

Процитировано

18

THE ROLE OF TRANSFORMING GROWTH FACTOR Β IN CERVICAL CARCINOGENESIS DOI
Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Eliza Pizarro Castilha

и другие.

Cytokine & Growth Factor Reviews, Год журнала: 2024, Номер unknown

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

6

Cervical Cancer DOI
Vikrant V. Sahasrabuddhe

Hematology/Oncology Clinics of North America, Год журнала: 2024, Номер 38(4), С. 771 - 781

Опубликована: Май 16, 2024

Язык: Английский

Процитировано

5

Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies DOI
Jing Wang, Qixin Wang, Ling Ma

и другие.

Molecular Therapy, Год журнала: 2024, Номер 32(7), С. 2340 - 2356

Опубликована: Май 6, 2024

Язык: Английский

Процитировано

4